Sunday, September 14, 2025
spot_img

South Africa set to participate in two more vaccine trials

Date:

Share post:

spot_imgspot_img

Johannesburg: South Africa is all set to participate in two more COVID-19 vaccine trials by leading pharmaceutical companies starting next month.

Dr Glenda Gray, president and CEO of the South African Medical Research Council, said in an interview with the public interest health website Spotlight on Tuesday that a Johnson & Johnson product called Ad26.COV2-S and a Novavax product called NVX-CoV2373 will be trialled in the country.

The first COVID-19 vaccine trial on the African continent was the Ox1Cov-19 Vaccine VIDA trial, a collaboration with Oxford University, which was started in June in South Africa.

It is led by Professor in Vaccinology at Wits University Shabir Madhi.

Madhi, who is also the lead investigator for the Novavax trial in South Africa, told Spotlight that the Novavax trial to be conducted in South Africa will be a Phase IIb trial, which would measure efficacy, but not to the extent required for registration, for which a Phase III trial is typically needed. (Pti)

spot_imgspot_img

Related articles

Three arrested for gang-raping woman in Bhubaneswar hotel

Bhubaneswar, Sep 14 : Three persons have been arrested in connection with the gang-rape of a woman, who...

Raipur likely to adopt Police Commissioner System from November 1

Raipur, Sep 14: In a significant administrative overhaul, Raipur (Chhattisgarh) is set to implement the Police Commissioner System...

Counter-terrorist mock exercise at Delhi Airport to test crisis preparedness

New Delhi, Sep 14 : Delhi’s Indira Gandhi International Airport on Sunday witnessed a large-scale Joint Counter Terrorist...

CM Stalin calls ‘Mupperum Vizha’ show of unity ahead of 2026 Assembly elections

Chennai, Sep 14:Chief Minister of Tamil Nadu and DMK president M.K. Stalin has said that the upcoming 'Mupperum...